Loading…
Data as of .
| Company | Industry | Market cap | 1M | 6M | Revenue growth | Op. margin | Fwd P/E |
|---|---|---|---|---|---|---|---|
| CSL CSL.AX | Biotechnology | $67.2B | +11% | +105% | -2% | 26% | 22.4× |
| Sigma Healthcare SIG.AX | Pharmaceuticals: Major | $22.4B | +8% | -1% | +209% | 9% | 37.1× |
| Pro Medicus PME.AX | Services to the Health Industry | $14.8B | +29% | +63% | +23% | 75% | 112.9× |
| Ramsay Health Care RHC.AX | Hospital/Nursing Management | $8.87B | +2% | +52% | +4% | 5% | 32.4× |
| Cochlear COH.AX | Medical Specialties | $7.05B | +21% | +55% | -1% | 13% | 29.4× |
| Sonic Healthcare SHL.AX | Medical/Nursing Services | $6.87B | +7% | +6% | +14% | 9% | 16.8× |
| Telix Pharmaceuticals TLX.AX | Biotechnology | $3.22B | -14% | -6% | +27% | -1% | 36.8× |
| EBOS EBO.AX | Medical Specialties | $2.52B | +14% | +1% | +3% | 3% | 15.2× |
| Neuren Pharmaceuticals NEU.AX | Pharmaceuticals: Generic | $2.04B | +15% | +83% | -68% | 20% | 39.5× |
| Mesoblast MSB.AX | Biotechnology | $1.83B | +5% | 0% | +556% | -43% | n/a |
| PYC Therapeutics PYC.AX | Pharmaceuticals: Major | $1.28B | -26% | +31% | n/a | n/a | n/a |
| Regis Healthcare REG.AX | Medical/Nursing Services | $1.05B | +16% | -17% | +17% | 4% | 25.1× |
| Nanosonics NAN.AX | Medical Specialties | $599M | +3% | -13% | +3% | 7% | 90.3× |
| Integral Diagnostics IDX.AX | Medical/Nursing Services | $450M | -18% | -21% | +26% | 9% | 15.5× |
| Polynovo PNV.AX | Biotechnology | $426M | -3% | -12% | +13% | 5% | 89.0× |
| Australian Clinical Labs ACL.AX | Medical/Nursing Services | $419M | +16% | +74% | -1% | 8% | 17.3× |
| Clarity Pharmaceuticals CU6.AX | Medical Specialties | $386M | -24% | -48% | n/a | n/a | n/a |
| Australian Unity Ltd Pref AYUPA.AX | Medical/Nursing Services | $353M | +11% | +6% | 0% | -2% | n/a |